Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00191490What this trial is testingStudy Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 162
Testing effectiveness (Phase 2)Study completedNCT01310816What this trial is testingA Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) ChondrosarcomaWho this might be right forConventional Chondrosarcoma Infinity Pharmaceuticals, Inc. 105
Testing effectiveness (Phase 2)Looking for participantsNCT05440708What this trial is testingTTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Tvardi Therapeutics, Incorporated 193
Testing effectiveness (Phase 2)UnknownNCT04211012What this trial is testingA Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial CarcinomaWho this might be right forUrothelial Carcinoma Jun Guo 30
Not applicableLooking for participantsNCT07096258What this trial is testingEMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC PatientsWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Hedera Dx SA 1,000
Large-scale testing (Phase 3)Study completedNCT01440088What this trial is testingA Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaWho this might be right forSoft Tissue Sarcoma Threshold Pharmaceuticals 640
Testing effectiveness (Phase 2)Active Not RecruitingNCT03547973What this trial is testingStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadWho this might be right forMetastatic Urothelial Cancer Gilead Sciences 502
Testing effectiveness (Phase 2)Looking for participantsNCT07359820What this trial is testingLirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or RearrangementWho this might be right forFGFR2 Gene Fusion/RearrangementOther Solid Tumors, Adult Elevar Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT01661179What this trial is testingEvaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaWho this might be right forUnresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma Genzyme, a Sanofi Company 14
Early research (Phase 1)Active Not RecruitingNCT07131189What this trial is testingFL115 Monotherapy in Unresectable or Metastatic Solid TumorsWho this might be right forLocally Advanced/Metastatic Solid Tumors Suzhou Forlong Biotechnology Co., Ltd 30
Testing effectiveness (Phase 2)Looking for participantsNCT07450976What this trial is testingSHR-A1904 in Previous Systemic Treatment Failed Biliary Tract CancerWho this might be right forBiliary Tract Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 151
Testing effectiveness (Phase 2)Ended earlyNCT00089102What this trial is testingGemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer Medical University of South Carolina 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664What this trial is testingTrametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally AdvancedWho this might be right forMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more M.D. Anderson Cancer Center 37
Early research (Phase 1)Looking for participantsNCT04878029What this trial is testingCabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial CancerWho this might be right forInfiltrating Bladder Urothelial Carcinoma With Squamous DifferentiationLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+1 more Emory University 32
Large-scale testing (Phase 3)Looking for participantsNCT06081959What this trial is testingStudy of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerWho this might be right forMetastatic Breast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Ended earlyNCT05583110What this trial is testingEfficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast CancerWho this might be right forHER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma Spanish Breast Cancer Research Group 13
Testing effectiveness (Phase 2)Ended earlyNCT00354224What this trial is testingCapecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach CancerWho this might be right forGastric Cancer Medical University of South Carolina 10
Testing effectiveness (Phase 2)Ended earlyNCT04800627What this trial is testingPevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid TumorWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT04934618What this trial is testingA Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric CancerWho this might be right forGastric Cancer Nanfang Hospital, Southern Medical University 85